They achieve this without posing an inherent danger of hypoglycemia by raising endogenous glucagon-like peptide 1 (GLP-1) concentrations, which cause stimulation of insulin release while inhibiting glucagon secretion. This evidence concerns the gene GCG and Hypoglycemia.